The fine chemical industry thrives on the precise identification and reliable supply of specialized compounds that serve as the building blocks for a myriad of applications, most notably in pharmaceutical research. Among these critical substances is Morphinan, 3-methoxy-17-methyl-, hydrobromide, hydrate, identified by its Chemical Abstracts Service (CAS) number 6700-34-1. This morphinan derivative holds significant importance as a fine chemical, underpinning advancements in drug discovery and development.

The chemical properties of CAS 6700-34-1 are central to its utility. As a morphinan structure, it possesses a characteristic ring system that is foundational to a range of biologically active molecules. The specific substituents and salt form (hydrobromide hydrate) contribute to its stability and handling characteristics, making it suitable for various chemical reactions. Researchers often investigate these morphinan derivative synthesis routes to optimize yields and purity, essential factors when dealing with compounds destined for pharmaceutical use. The meticulous nature of fine chemical production ensures that substances like 6700-34-1 meet exacting standards, enabling predictable outcomes in complex synthetic endeavors.

The role of this compound extends to its relationship with known drugs, such as dextromethorphan, highlighting the potential for new therapeutic applications. By understanding the chemical synthesis and availability of such intermediates, the pharmaceutical sector can accelerate its pipeline. The price and accessibility of these fine chemicals directly impact the feasibility of large-scale production and clinical trials. As the demand for targeted therapies grows, the importance of reliable access to precisely characterized compounds like 6700-34-1 becomes even more pronounced, solidifying its position as a key element in the modern drug discovery ecosystem.